This site is intended for healthcare professionals
Drug information

Transiderm-Nitro

OTC
Read time: 8 mins
Last updated: 16 Jan 2020
Published: 24 Jul 2020

4.1 Therapeutic indications

Prophylactic treatment of attacks of angina pectoris, as monotherapy or in combination with other anti-anginal agents.

Transiderm Nitro 5 only: Prophylactic treatment of phlebitis and extravasation secondary to venous cannulation for intravenous fluid and drug administration when the duration of treatment is expected to last for 2 days or longer.

Register free for full access to medthority.com

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

 

 

Disclaimer

The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.

Medthority will not be held liable for explicit or implicit errors, or missing data.

Reporting of suspected adverse reactions 

Drug Licencing

Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).